Outcomes of Cardiogenic Shock With Autoimmune Rheumatological Disorders
Abstract
Aims
Data on cardiogenic shock (CS) in autoimmune diseases (AID) is limited. Our study aims to evaluate in-hospital outcomes of CS in hospitalized patients with underlying AID compared with patients without AID.